Papoutsanis
Papoutsanis (PAP) closed at €3.31 on 26/10/2026, -0.90% on the day. Market cap €89.7m, P/E 18.2, dividend yield 3.02%.
Latest results · 21/10/2026
Papoutsanis 9M 2026 (vs 9M 2025): revenue €63,651,874 (€58,596,134, +8.6%); gross profit €22,678,014 (€20,181,469, +12.4%); profit before tax €6,312,273 (€5,303,175, +19.0%); net profit €5,231,322 (€4,796,292, +9.1%); EBITDA €9,438,916 (€8,473,891, +11.4%). Exports were 56% of turnover. Outlook: "For the full year 2026, Papoutsanis management confirms its estimate for double-digit revenue growth". From 2026, certain discounts are granted via credit note, affecting sales presentation with a corresponding reduction in selling expenses and no impact on final profitability.
Source: athens.euronext.com · 21/10/2026
Announcements to the exchange
- 23/10/2026 10:08Additional Announcement for the payment of the interim dividend for the financial year 2026
- 22/10/2026 09:30PAPOUTSANIS - COMPANY PRESENTATION INVESTOR DAY OCTOBER 2026
- 21/10/2026 09:50PAPOUTSANIS: Nine Month Financial Results 2026
- 06/10/2026 18:02TURNOVER ANNOUNCEMENT FOR THE 9 MONTHS 2026
Key statistics
FY2025 unless a figure says otherwise
Profile
At the 26 Oct close- Market value
- €89.7m
- Enterprise valueDec 2025est.
- €108m
- Shares outstandingOct 2026
- 27.1m
- RevenueFY2025
- €79.9m
- Employees
- 233
- Free floatest.
- 25.8%
- Traded a day, 3-month average
- €63.9k
Valuation
FY2025- P/EFY2021
- 18.2×
- P/B
- 3.5×
- EV/Salesest.
- 1.4×
- EV/EBITDAest.
- 9.5×
- P/FCFFY2021
- —
- Dividend yield
- 3.0%
5 years, on reported full years: 8.7–12.3×, median 9.6×. Today 9.5×, lower than 57% of months.
not meaningful here
Margins
FY2021- Gross
- 32.5%
- EBITDAFY2025
- 14.3%
- Pre-tax
- 11.1%
- NetFY2025
- 7.8%
- Free cash flow
- −0.3%
Net margin = the shareholders' profit ÷ group revenue.
Returns
FY2021- ROA
- 7.7%
- Tax rate
- 19.9%
Financial health
Dec 2025- CashDec 2021
- €6.4m
- Net debt
- €18.4m
- Net debt ÷ EBITDA
- 1.6×
Growth
- Revenue, last yearFY2025
- +20.6%
- Revenue, 3 yearsFY2022–25, a year
- +4.1%
- Revenue, 5 yearsFY2020–25, a year
- +14.4%
Dividends
FY2025- Yield, last 12 months
- 3.0%
- Per share
- €0.090
- Years paid, last fiveFY2021–25
- 5
Trading and risk
From our closes, dividends reinvested- Total return, 1 year
- +12.4%
- 3 years, a year
- +18.9%
- 5 years, a year
- +10.8%
- 10 years, a year
- +29.0%
- Volatility, 1 year
- 30.1%
- Beta to the General Index
- 0.40×
- Deepest fall, 1 year / 5 years
- −19.0% / −36.1%
- 52-week range
- €2.91–€3.99
Where the figures come from: the company's reports, reviewed by us · annual accounts filed in ESEF format · results announcements on the exchange · our own closing prices. No forecasts or target prices are stored.
Financial charts
From the stored figures: the reviewed dossier first, then the annual reports (ESEF) and results announcements
Loading the charts…
Valuation
vs SAR| Metric | PAP | SAR |
|---|---|---|
| P/E | 18.2 | — |
| P/B | 3.5 | 1.8 |
| P/S | 1.1 | 1.2 |
| EV/EBITDA | 9.5 | — |
| Dividend yield | 3.0% | 3.5% |
| Payout ratio | — | 47.4% |
| Gross margin | 32.5% | 37.1% |
| Net margin | 7.8% | — |
| Revenue growth (last full year) | 20.6% | −0.1% |
| Net debt | €18.4m | −€23.5m |
Peers: Personal & home care
The company
AI-draftedPapoutsanis manufactures branded personal and home-care products, hotel amenities, third-party products and specialty soap bases at its Chalkida-area plant. Exports were 56% of nine-month 2026 sales.
- Oct 2026At its Investor Day management set a €150m revenue aspiration for 2031 with a 16% EBITDA margin.10
- Oct 2026Nine-month 2026 revenue rose 8.6% to €63.7m and EBITDA 11.4% to €9.4m.9
- Oct 2026The CEO raised his voting stake to 26.52%; the chair had disclosed a cut in his own to 20.13% in September.13,4
- Oct 2026The buyback continued: 30,812 own shares (0.114%) held on 20 October.11,12
- Aug 2026An FY2026 interim dividend of approximately €0.05 gross per entitled share was declared, with payment scheduled from 2 November 2026.6,7
- Apr 2026The AGM approved a €0.09 FY2025 cash dividend and a separate treasury-share distribution.5
- 9M 2025 sales were restated from €61.0m to €58.6m for customer-discount presentation.8
- For FY2026 management expects double-digit revenue growth and a double-digit rise in pre-tax profit.9
- Management targets €150m revenue by 2031, a 16% EBITDA margin and a payout of at least 30%; these are targets, not guarantees.10
- The FY2025 cash distribution was €0.09/share, with a separate treasury-share distribution.5
- A buyback is under way; the company held 30,812 own shares (0.114%) after 20 October.11
- 1.H1 2026 financial reportPapoutsanis · 04/08/2026official
- 2.FY2025 annual financial reportPapoutsanis · 16/03/2026official
- 3.FY2025 analysts briefingPapoutsanis · 03/2026official
- 4.Gatzaros stake notificationPapoutsanis · 18/09/2026official
- 5.AGM resolutionsPapoutsanis · 17/04/2026official
- 6.FY2026 interim dividendPapoutsanis · 24/08/2026official
- 7.Revised financial calendarPapoutsanis · 08/09/2026official
- 8.Turnover announcement for the 9 months 2026Papoutsanis · 06/10/2026official
- 9.Financial results for the first nine months of 2026Papoutsanis · 21/10/2026official
- 10.Investor Day Athens 2026 presentationPapoutsanis · 22/10/2026official
- 11.Own-share acquisition notice, 20 October 2026Papoutsanis · 21/10/2026official
- 12.Own-share acquisition notice, 17 September 2026Papoutsanis · 18/09/2026official
- 13.Tassopoulos purchase and stake notificationPapoutsanis · 22/10/2026official